凝块的蛋白质组分析在接受内血管治疗的患者中确定了中风病因
Tae Jung Kim1,2, Jin Woo Jung3,4, Young-Ju Kim1
1Department of Neurology, Seoul National University College of Medicine, Seoul, Korea.
CNS neuroscience & therapeutics
|March 13, 2025
概括
对接受内血管治疗的中风患者血栓的蛋白质组分析确定了特定的蛋白质标记物. 这些标记物可以区分中风机制,有助于二次预防策略.
科学领域:
- 神经学 神经学
- 蛋白质组学是指蛋白质组学.
- 生物化学 生物化学
背景情况:
- 缺血性中风有各种潜在的机制,包括心血管栓塞 (CE),大动脉动脉样硬化 (LAA) 和与癌症相关的 (CR) 原因.
- 准确识别中风机制对于有效的二次预防策略至关重要.
- 内血管治疗 (EVT) 是急性缺血性中风的常见治疗方法,可提供凝块样本进行分析.
研究的目的:
- 在接受EVT的患者中调查凝块组成和中风机制之间的相关性.
- 在检索到的血块中识别特定的蛋白质标记物,这些标记物可以区分CE,LAA和CR中风机制.
- 开发一种机器学习模型,以基于凝块蛋白质组形状来预测中风机制.
主要方法:
- 从接受EVT的35名缺血性中风患者中提取的血栓的蛋白质组分析.
- 鉴定与CE,LAA和CR中风机制相关的差异表达蛋白质.
- 开发和应用机器学习模型,利用蛋白质标记器预测中风机制.
主要成果:
- 在初步分析中确定了3838种蛋白质;经验证后选择了34种候选蛋白质.
- 一个机器学习模型确定了区分中风机制的特定蛋白质:Pleckstrin (CE),CD59糖蛋白 (LAA) 和免疫球蛋白重常量玛1 (CR).
- 这些蛋白质标记物也在未确定中风原因的患者中被确定,有助于阐明机制.
结论:
- 凝块中的特定蛋白质标记物可以在接受EVT的患者中区分中风机制.
- 鉴定出来的蛋白质标记为我们提供了关于缺血性中风的潜在原因的见解.
- 这些发现可能有助于制定更有效的二次预防策略,以适应特定的中风机制.
相关概念视频
Clot Retraction and Fibrinolysis
3.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
586
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
586


